top of page
Now Offering No-Cost Clinical Autoantibody Testing — through the STOP T1D Screening Program
STOP T1D offers health care providers access to clinical autoantibody testing through the Barbara Davis Center for Diabetes (BDC) Autoantibody Laboratory — with NO COST to your practice or your patients.*
Bring Early Type 1 Diabetes Screening into Your Practice
1
Collect Sample
2
Ship to BDC
3
Receive Results
Participating providers collect a small blood sample and ship it directly to the BDC Autoantibody Laboratory. Testing is performed using a highly sensitive electrochemiluminescence (ECL) assay to detect type 1 diabetes autoantibodies (GAD, IA-2, insulin, ZnT8), and the tissue transglutaminase autoantibody (TG) — a marker of celiac disease. Results are returned within 1–2 weeks to the requesting provider.
* Funding support available now through 12/31/26. Practices are responsible for supplies, sample collection and shipping.
Getting Started is Easy
1. Fill out this form to initiate enrollment in this program.
2. A STOP T1D team member will reach out to schedule a call.
This program was developed independently by the Barbara Davis Center for Diabetes and supported in part by a grant from Sanofi US.
Version 3.0_10.2025 / Design/Website: GSU
bottom of page